These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 5453682

  • 21. Ethambutol in primary childhood tuberculosis.
    Patwardhan P, Bhatia M, Merchant SM.
    Indian Pediatr; 1970 Apr; 7(4):194-201. PubMed ID: 5311827
    [No Abstract] [Full Text] [Related]

  • 22. [A study on short-course chemotherapy for pulmonary tuberculosis. Initial intensive regimens containing streptomycin].
    Suzuyama Y, Shigeno Y, Shigeno H, Nakazato H, Nagasawa M, Koga H, Tomita H, Tomonaga A, Yamaguchi K, Izumikawa K.
    Kekkaku; 1984 Apr; 59(4):277-87. PubMed ID: 6748457
    [No Abstract] [Full Text] [Related]

  • 23. Drug-resistant tuberculosis in Budapest.
    Fodor T, Vadász I, Lõrinczi I.
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [Abstract] [Full Text] [Related]

  • 24. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T.
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract] [Full Text] [Related]

  • 27. Ethambutol/INH. in the initial treatment of pulmonary tuberculosis.
    Ng KC.
    Singapore Med J; 1971 Jun; 12(3):161-5. PubMed ID: 5094425
    [No Abstract] [Full Text] [Related]

  • 28. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS.
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract] [Full Text] [Related]

  • 29. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ, Palma Beltrán O, Abbate E, Dambrosi A, Mosca C.
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract] [Full Text] [Related]

  • 30. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W, Krawczyk Z, Górnicka-Wilczyńska M, Pilarska-Machowicz A, Pruszyńska S, Pawlik J, Wardowa A, Woźniak B, Tomaszkiewicz L.
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract] [Full Text] [Related]

  • 31. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
    Szymanski A, Gaik A.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981 Nov; 30(3):181-3. PubMed ID: 6273991
    [No Abstract] [Full Text] [Related]

  • 32. [Biweekly treatment of pulmonary tuberculosis with isoniazid and streptomycin, with or without initial continuous phase. Results obtained in Algiers].
    Larbaoui D, Abderrahim K.
    Rev Tuberc Pneumol (Paris); 1968 Jun; 32(4):572-3. PubMed ID: 5758995
    [No Abstract] [Full Text] [Related]

  • 33. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 34. [Intensive chemotherapy of pulmonary tuberculosis].
    Shesterina MV, Gavrilenko VS, Tarasova EF, Sokolova GV, Tregubov IuG.
    Probl Tuberk; 1980 Jul; (7):20-22. PubMed ID: 6997865
    [No Abstract] [Full Text] [Related]

  • 35. Tuberculosis treatment: dangerous regimens?
    Rieder HL, Arnadottir T, Trébucq A, Enarson DA.
    Int J Tuberc Lung Dis; 2001 Jan; 5(1):1-3. PubMed ID: 11263509
    [No Abstract] [Full Text] [Related]

  • 36. Clinical experience with isobutol: a new molecular combination of ethambutol-INH.
    Leonin TA.
    Kekkaku; 1981 Feb; 56(2):63-8. PubMed ID: 7265605
    [No Abstract] [Full Text] [Related]

  • 37. [Complex hospital treatment of pulmonary tuberculosis].
    Bondarev IM, Batmanov NIa, Shesterina MV, Gavrilenko VS, Tarasova EF.
    Sov Med; 1980 Feb; (6):79-82. PubMed ID: 6998023
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative therapeutic survey of 2 intermittent drug therapies. (Isoniazid (INH), ethionamid (ETA) and streptomycin (SM), isoniazid (INH). Results with 965 patients. Antituberculosis services in Morocco and Senegal].
    Burzoni F, Durante C, Chicou J, Hétrick G, Munoz I, Ras R, Brunel, Rabier.
    Rev Tuberc Pneumol (Paris); 1970 Feb; 34(5):671-3. PubMed ID: 5496789
    [No Abstract] [Full Text] [Related]

  • 39. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR.
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [Abstract] [Full Text] [Related]

  • 40. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E.
    Wien Med Wochenschr; 1966 Nov 19; 116(47):996-8. PubMed ID: 6011782
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.